The Haystack Project
  • Home
  • About Us Participants Partners Board and Advisors
  • Priorities
  • PROTECT Rare
  • Rare Disease Approvals HEART Act
  • Speaker Series Payer Engagement Health Equity Rare Cancer
  • Inflation Reduction Act Medicare Section 340b Medicaid FDA ICER
  • Patient Stories
  • Join
  • Take Action
The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
Blue-Banner.png
The Haystack Project

Resources

The Haystack Project
  • Home/
  • About/
    • About Us
    • Participants
    • Partners
    • Board and Advisors
  • Priorities/
  • PROTECT Rare/
  • FDA/
    • Rare Disease Approvals
    • HEART Act
  • Programs/
    • Speaker Series
    • Payer Engagement
    • Health Equity
    • Rare Cancer
  • Policy/Comments/
    • Inflation Reduction Act
    • Medicare
    • Section 340b
    • Medicaid
    • FDA
    • ICER
  • Patient Stories/
  • Join/
  • Take Action/
July 03, 2023

Haystack Comments on CMI's Proposed Rule on Ensuring Medicaid Access →

July 03, 2023/ Michelle Osburn

Read more.

July 03, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
Medicaid

Michelle Osburn

July 03, 2023

Haystack's comments on CMS’ proposed rule on the Medicaid and Children’s Health Insurance Program (CHIP) →

July 03, 2023/ Michelle Osburn

Read more.

July 03, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
cms, CHIP, Medicare, Medicaid

Michelle Osburn

June 20, 2023

Haystack Submits Feedback on the Counteroffer ICR→

June 20, 2023/ Michelle Osburn

Read more.

June 20, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
IRA

Michelle Osburn

June 09, 2023

Haystack comments on CMS' proposed rule to update IPPS→

June 09, 2023/ Michelle Osburn

Read more.

June 09, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicare

Michelle Osburn

June 05, 2023

Haystack provides feedback on the upcoming implementation of the Inflation Reduction Act’s (IRA) provisions related to Medicare Part D redesign→

June 05, 2023/ Michelle Osburn

Read more.

June 05, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
IRA

Michelle Osburn

May 22, 2023

Haystack IRA data elements ICR 5.22.23

May 22, 2023/ Tiara Logan

Read here.

May 22, 2023/ Tiara Logan/ /Source
Letters, Comment Letters
Medicaid, medicare

Tiara Logan

May 05, 2023

Haystack's letter to NASEM Requesting a meeting regarding the HEART Act→

May 05, 2023/ Michelle Osburn

Read more.

May 05, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
HEART Act, GAO, NAM, FDA

Michelle Osburn

May 04, 2023

Haystack requests meeting with GAO leadership and staff→

May 04, 2023/ Michelle Osburn

Read more.

May 04, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
HEART Act, GAO, NAM, FDA

Michelle Osburn

April 14, 2023

Haystack's comments on CMS' issuance of its initial set of guidance on implementation of the Inflation Reduction Act of 2022→

April 14, 2023/ Michelle Osburn

Read more.

April 14, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
IRA

Michelle Osburn

March 27, 2023

Haystack's comments on the small biotech exception to the drug negotiation provisions of the Inflation Reduction Act→

March 27, 2023/ Michelle Osburn

Read more.

March 27, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
IRA

Michelle Osburn

March 14, 2023

Haystack's comments in response to CMS' Notice of proposed rulemaking on Advancing Interoperability & Improving Prior Authorization Processes→

March 14, 2023/ Michelle Osburn

Read more.

March 14, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicaid, medicare

Michelle Osburn

March 13, 2023

Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance→

March 13, 2023/ Michelle Osburn

Read more.

March 13, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicaid, medicare, IRA

Michelle Osburn

March 11, 2023

Haystack's comments in response to CMS' Medicare Part D Inflation Rebate Guidance→

March 11, 2023/ Michelle Osburn

Read more.

March 11, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicare, medicaid, IRA

Michelle Osburn

March 09, 2023

Haystack's Project Letter to FDA on the Implementation of the HEART Act→

March 09, 2023/ Michelle Osburn

Read more.

March 09, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
HEART Act, GAO, NAM, FDA

Michelle Osburn

March 03, 2023

Haystack's comment's on CMS' Advance Notice of Methodological Changes→

March 03, 2023/ Michelle Osburn

Read more.

March 03, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
payer engagement

Michelle Osburn

March 03, 2023

Haystack's comments on the PCORI's draft inventory of attributes→

March 03, 2023/ Michelle Osburn

Read more.

March 03, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
payer engagement

Michelle Osburn

February 13, 2023

Haystack's Comments on CMS Proposal to Oppose For Rare Diseases→

February 13, 2023/ Michelle Osburn

Read more.

February 13, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicaid, medicare

Michelle Osburn

January 30, 2023

Haystack's comments on CMS' RFI related to EHB under the ACA→

January 30, 2023/ Michelle Osburn

Read more.

January 30, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
medicaid, medicare, affordable care act

Michelle Osburn

January 30, 2023

Haystack's Sign-On Letter on Proposed Rule on Patient Protection and Affordable Care Act→

January 30, 2023/ Michelle Osburn

Read more.

January 30, 2023/ Michelle Osburn/ /Source
Comment Letters, Letters
patient protection, affordable care act

Michelle Osburn

January 13, 2023

Haystack's sign-on letter providing analysis of coverage with evidence development (CED) criteria →

January 13, 2023/ Michelle Osburn

Read more.

January 13, 2023/ Michelle Osburn/ /Source
Letters, Comment Letters
comment letter, medicare

Michelle Osburn

  • Previous
  • Next

About Us

The Issues

Resources

News & Updates

© 2020 Haystack Project. All Rights Reserved. 

 

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.